Skip to main content

We are relentless in our pursuit of a world without bleeds. Beyond delivering new medicines, we are dedicated in our efforts to encourage early diagnosis and propel patients towards optimal personalized care, and help them remain on the right therapy with the goal of achieving the best possible long-term outcomes.

We are investigating important scientific platforms, such as antibody and gene therapy, so that we are best positioned to discover innovative therapies tomorrow—while ensuring patients are cared for with use of our broad portfolio today.

We’re committed to caring for patients with bleeding disorders including Hemophilia and Von Willebrand Disease.

Powered by Firespring